Victrex plc · LSE:VCT

Victrex — H1 2015 Earnings Presentation

24 slides from Victrex's earnings presentation, May 19, 2015

  1. Slide 1: Victrex plc Interim results 19 May 2015

    Victrex plc Interim results 19 May 2015

  2. Slide 2: Welcome and introductions

    Welcome and introductions David Hummel Louisa Burdett Tim Cooper Martin Court Chief Executive Group Finance Director Managing Director VPS Managing Director Invibio 2

  3. Slide 3: Good first half progress

    Good first half progress A . aa v v ’ a av a a va A ATA, vy Ad ay \ y vA vVaha | oe AY Vv A aYey A 4 Va 4 vt +.V 4 A Via ‘ ‘ 4 14 a Vara . av’. ¢ A a v “VA victrex®

  4. Slide 4: Highlights H1 15: good progress

    Highlights H1 15: good progress • Revenue up 9%, PBT up 10% – Strong performance in VPS offsetting weaker Oil & Gas – Strong Consumer Electronics volumes; further potential through FY16 – Invibio focused on second half growth – Gross margin improvement to 65% driven by volume and efficiency • New pr

  5. Slide 5: Group income statement H1 15

    Group income statement H1 15 Half year ended 31 March H1 2015 H1 2014 Change £m £m % Revenue 130.3 120.0 9% Gross profit 84.5 76.8 10% Gross margin % 64.9% 64.0% 0.9% pts Overheads (30.8) (28.2) 9% Interest 0.2 0.3 (33%) Profit before tax 53.9 48.9 10% Earnings per share 49.8p 45.1p 10% • Good reven

  6. Slide 6: Gross margin improvement

    Gross margin improvement £/kg Average selling price (ASP) Gross margin (GM) % £90 100% £80 90% £76.4 £75.6 £75.8 80% £70 £67.4 £64.2 GM 66.6% GM 64.6% 70% £60 60% £50 50% £40 40% GM GM GM GM GM £30 66.0% 64.0% 65.1% 64.9% 67.2% 30% £20 20% £10 10% £0 0% H1 2013 H2 2013 H1 2014 H2 2014 H1 2015 • Gros

  7. Slide 7: Currency update

    Currency update Average exchange rates 2014 2015 2015 2016 Exchange rate H1 H1 Year * Year * sensitivity # $/£ 1.56 1.66 1.63 1.52 £6.0m €/£ 1.19 1.23 1.25 1.35 £3.8m ¥/£ 150 172 173 181 £0.7m • FY15 currency guidance unchanged: c£8m adverse at PBT level • 2015 & 2016 year estimates based on forecas

  8. Slide 8: Capacity and manufacturing update

    Capacity and manufacturing update • PPP3 proven capacity now online; Aptiv film capacity doubled • Enhanced downstream manufacturing capability: tape, pipe, medical • Retain strong Group gross margin despite mix 8

  9. Slide 9: VPS & Invibio performance update

    VPS & Invibio performance update Aerospace Automotive Electronics Energy / Industrial Medical 9

  10. Slide 10: VPS market highlights

    VPS market highlights • Transport volume up 6% • Aerospace – build rates driving growth • Automotive – core growth and new applications • Energy / Industrial volume down 2% • Oil & Gas – sales down 9%, principally E&P • Magma – revenue from ‘majors’ test programmes • Electronics volume up 135% • Apt

  11. Slide 11: Invibio market highlights

    Invibio market highlights • Invibio focused on H2 improvement: • H1 sales down 4% (flat in CC) driven by industry consolidation • Emerging market growth remains strong (Asia-Pacific up 26%) • Four PEEK-OPTIMA® HA-Enhanced approvals and first implants • New platforms progressing well: • Dental: Distr

  12. Slide 12: Strategic priorities

    Strategic priorities 1. Barriers to entry Barriers to entry Materials knowledge and know-how Proven capacity 2. 3. Focused R&D Downstream and prototyping manufacturing excellence capability and know-how VICTREX MOVING DOWNSTREAM OEM Materials manufacturer to solutions provider - Selling a solution,

  13. Slide 13: Further differentiation: technical excellence

    Further differentiation: technical excellence New Polymer Innovation Centre (UK) Selling a solution – not only materials - World class Polymer Innovation Centre to accelerate prototyping - Capability to deliver total solutions for OEMs - Investment within forward capex guidance; completion FY17 Chin

  14. Slide 14: Strong and focused pipeline

    Strong and focused pipeline • Seven “mega-programmes” >£50m 100% annual revenue potential (peak year) • Supported by several “major programmes” • Mature Annualised Volume up 10% • Market opportunity >80,000 tonnes Probability of Success 0% Time to meaningful revenue KEY: Annual revenue potential in

  15. Slide 15: Group outlook: H2 2015

    Group outlook: H2 2015* Aerospace Key: Optimistic Automotive Neutral Electronics Cautious Medical (Spine) Medical (other markets) Energy / Industrial * Indicative outlook for our markets for H2 2015 * Medium/long term structural growth drivers remain strong 15

  16. Slide 16: H2 15: Our focus

    H2 15: Our focus Build up new proven capacity - Underpin core demand and support future growth Maintain positive momentum: overcome FX impact - Drive core VPS and Consumer Electronics - Invibio focused on second half growth - Drive development of new mega-programmes Capital allocation and investment

  17. Slide 17: Appendix slides

    Appendix slides An innovative world leader in high performance polymer solutions 4 AA 17 . victrex

  18. Slide 18: Group end markets by volume

    Group end markets by volume H1 2015: 2,028 tonnes (H1 2014: 1,584 tonnes) Volume by Region Volume by Industry Medical * -11% Asia-Pacific EMEA +158% +0% Energy / Industrial -2% Electronics +135% Transport Americas +6% -4% * Medical volume reflects both non-implantable and implantable volumes 18

  19. Slide 19: Invibio: key markets

    Invibio: key markets H1 2015: £25.9m Revenue by Region Revenue by Market (H1 2014: £26.9m) Asia-Pacific Other markets +26% +2% Spine -4% EMEA Arthroscopy -5% -7% Americas -6% 19

  20. Slide 20: Business unit income statements

    Business unit income statements VPS Invibio Half year ended 31 March 2015 2014 Change 2015 2014 Change £m £m % £m £m % Revenue 104.4 93.1 12% 25.9 26.9 (4%) Gross profit 61.6 53.2 16% 22.9 23.6 (3%) Gross margin 59.0% 57.1% 1.9% pts 88.4% 87.7% 0.7% pts From 1 October 2014, management of sales, mark

  21. Slide 21: Strong cash from operations

    Strong cash from operations Half year ended 31 March 2015 2014 £m £m Operating profit 53.7 48.6 (Increase)/decrease in inventories (3.1) 2.5 Decrease/(increase) in trade and other receivables 1.2 (2.7) Increase in trade and other payables 2.0 1.2 Depreciation 5.5 4.8 Other 1.6 (1.3) Cash generated f

  22. Slide 22: Strong balance sheet

    Strong balance sheet 31 March 31 March 2015 2014 £m £m PPE and intangible assets 260.3 210.9 Inventories 49.5 47.9 Cash 42.2 79.4 Trade receivables and other assets 47.7 42.9 Retirement benefit obligations (7.4) (3.4) Trade payables and other liabilities (66.4) (51.7) Equity shareholders' funds 325.

  23. Slide 23: Development pipeline by volume

    Development pipeline by volume PIPELINE BY VOLUME Mature Annualised Other 3% Volume 2,365 tonnes (FY 2014: 2,141 tonnes) • Mature Annualised Volume (MAV) up 10% • Horizon 1 average target size now 1.8 tonnes (September 2014: 1.4 tonnes) 23

  24. Slide 24: Further information and contacts

    Further information and contacts: ir@victrex.com www.victrexplc.com Andrew Hanson Head of Investor Relations & Communications +44 (0) 1253 898121

Victrex — H1 2015 Earnings Presentation on 6ix